Carbonell, D.; Chicano, M.; Cardero, A.J.; Gómez-Centurión, I.; Bailén, R.; Oarbeascoa, G.; MartÃnez-SeñarÃs, D.; Franco, C.; Muñiz, P.; Anguita, J.;
et al. FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia. Cancers 2022, 14, 4006.
https://doi.org/10.3390/cancers14164006
AMA Style
Carbonell D, Chicano M, Cardero AJ, Gómez-Centurión I, Bailén R, Oarbeascoa G, MartÃnez-SeñarÃs D, Franco C, Muñiz P, Anguita J,
et al. FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia. Cancers. 2022; 14(16):4006.
https://doi.org/10.3390/cancers14164006
Chicago/Turabian Style
Carbonell, Diego, MarÃa Chicano, Alfonso J. Cardero, Ignacio Gómez-Centurión, Rebeca Bailén, Gillen Oarbeascoa, Diana MartÃnez-SeñarÃs, Carolina Franco, Paula Muñiz, Javier Anguita,
and et al. 2022. "FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia" Cancers 14, no. 16: 4006.
https://doi.org/10.3390/cancers14164006
APA Style
Carbonell, D., Chicano, M., Cardero, A. J., Gómez-Centurión, I., Bailén, R., Oarbeascoa, G., MartÃnez-SeñarÃs, D., Franco, C., Muñiz, P., Anguita, J., Kwon, M., DÃez-MartÃn, J. L., Buño, I., & MartÃnez-Laperche, C.
(2022). FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia. Cancers, 14(16), 4006.
https://doi.org/10.3390/cancers14164006
